Evidence map›Paper›PMID 35589716›Full record

ArticleNature communications2022

Structural insights into the mechanism of pancreatic K

Mengmeng Wang, Jing-Xiang Wu, Dian Ding, Lei Chen

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Inhibition Mechanism of Pancreatic KResearch (Washington, D.C.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Bayliss-Starling Prize Lecture: KThe Journal of physiology · 2025
    Article
  7. Article
  8. Dynamic duo: Kir6 and SUR in KChannels (Austin, Tex.) · 2024
    Review
  9. Article
  10. Structure of an open KNature communications · 2024
    Article
  11. Non-radioactive RbMethods in molecular biology (Clifton, N.J.) · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. KCurrent opinion in structural biology · 2023
    Review
  16. Article
  17. Personalized Therapeutics for KAnnual review of pharmacology and toxicology · 2023
    Review
  18. Review
  19. KFrontiers in endocrinology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mengmeng WangState Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, 100871, Beijing, China.ORCID 0000-0003-0587-4439
Jing-Xiang WuState Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, 100871, Beijing, China.
Dian DingState Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, 100871, Beijing, China.
Lei ChenState Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, 100871, Beijing, China. chenlei2016@pku.edu.cn.ORCID 0000-0002-7619-8311

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ATP-sensitive potassium channels (K

Indexed as

Adenosine TriphosphateKATP ChannelsAdenosine DiphosphateHumansPancreasSulfonylurea ReceptorsAdenosine DiphosphateAdenosine TriphosphateKATP ChannelsSulfonylurea Receptors

Identifiers

PMID35589716
PMCPMC9120461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.